Exacerbation of oxaliplatin neurosensory toxicity following surgery
نویسندگان
چکیده
منابع مشابه
Exacerbation of oxaliplatin neurosensory toxicity following surgery.
Combination of chemotherapy and surgical resection of metastases is the most promising strategy to improve the fraction of long-term survivors and cured patients in metastatic colorectal cancer. We reproducibly observed evidence of exacerbation of the oxaliplatin-induced neurosensory toxicity following surgery. Total, protein-bound and intra-erythrocytic concentrations of oxaliplatin were measu...
متن کاملRisk Factors of Neurosensory Disturbance following Orthognathic Surgery
OBJECTIVES To report the incidence of objective and subjective neurosensory disturbance (NSD) after orthognathic surgery in a major orthognathic centre in Hong Kong, and to investigate the risk factors that contributed to the incidence of NSD after orthognathic surgery. MATERIALS AND METHODS A retrospective cross-sectional study on NSD after orthognathic surgery in a local major orthognathic ...
متن کاملOxaliplatin-Related Ocular Toxicity
We report the case of a 52-year-old woman with advanced colorectal cancer who was treated with oxaliplatin on a FOLFOX schedule. After 3 cycles of chemotherapy, she started to complain of visual loss, altered color vision and neurological symptoms. Due to the suspicion of ocular and neurological toxicity, antineoplastic treatment was stopped. Her visual field showed a concentric bilateral scoto...
متن کاملNeurosensory Disturbance following Bilateral Sagittal Split Osteotomy Surgery for Mandibular Advancement
Bilateral Sagital Split Osteotomy (BSSO) is one of the most common surgeries for the management of mandibular retrognathism. However, nerve damage and lip paresthesia is possible after the surgery. The aim of the present study was to evaluate the incidence of neurosensory disturbance after BSSO surgery. 42 patients in need of mandibular advancement participated in this study. The sensory status...
متن کاملOxaliplatin toxicity masquerading as recurrent colon cancer.
IN REPLY: The letter of Dr Altundag et al raises a few important questions for the interpretation of circulating DNA levels. With respect to human telomerase reverse transcriptase (hTERT) specificity, it was not our intention to use hTERT genomic amplification as a tumor-associated marker, but instead, we simply used it as a marker to quantify , by real-time polymerase chain reaction, the total...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2002
ISSN: 0923-7534
DOI: 10.1093/annonc/mdf254